HOLX - Hologic Inc Profile, Share Price, Market Analysis, Charts, Fundamentals

Business Description

Hologic Inc. is a prominent US-based medical technology company that concentrates on diagnostic, surgical, and medical imaging equipment primarily for womens health. With its headquarters in Marlborough, Massachusetts, Hologic operates in over 50 countries, making a significant global impact in the healthcare sector.

Founded in 1985, Hologic initially centered its efforts on developing products for osteoporosis diagnostics. Over the years, the company has significantly broadened its portfolio, now encompassing a diverse range of diagnostic and medical imaging equipment designed for cancer detection, gynecology, and skeletal health. Hologic also manufactures surgical products and accessories specifically tailored for diagnostic imaging and breast biopsy procedures.

The company is recognized for its innovative imaging technologies, particularly its introduction of the first FDA-approved 3D mammography system, the Selenia Dimensions digital breast tomosynthesis (DBT) system, in 2011. This advanced system utilizes low-dose X-rays to produce multi-layered images of the breast, which enhances detection rates while reducing the need for follow-up biopsies.

Hologics suite of advanced technologies extends beyond imaging. The Panther Fusion system is a noteworthy product for molecular diagnostic testing, while NovaSure addresses heavy menstrual bleeding through endometrial ablation. The MyoSure device is designed for the removal of uterine fibroids and polyps. Furthermore, Hologic offers a variety of services supporting womens health, including prenatal testing and infertility treatment.

A reputation for quality and commitment to patient outcomes underscores Hologics standing in the medical industry. The company continues to invest heavily in research and development, striving to uncover innovative solutions that enhance womens health while pushing the boundaries of diagnostics and medical imaging.

In addition to its focus on health outcomes, Hologic is also dedicated to sustainability and corporate responsibility. The company actively pursues strategies to minimize its environmental impact, uphold ethical business standards, and foster diversity and inclusion within its workforce.

In summary, Hologic Inc. stands at the forefront of medical technology, delivering state-of-the-art diagnostic, surgical, and imaging solutions centered on womens health. Its ongoing commitment to innovation, patient care, and corporate responsibility solidifies its position as a leader in the industry.

Fundamental Analysis

United States

0 %

of total Revenue

International

30.23 %

of total Revenue

Diagnostics

51.18 %

of total Revenue

Diagnostics United States

37.44 %

of total Revenue

Diagnostics International

13.74 %

of total Revenue

Diagnostics Cytology Perinatal

13.97 %

of total Revenue

Diagnostics Cytology Perinatal United States

8.38 %

of total Revenue

Diagnostics Cytology Perinatal International

5.6 %

of total Revenue

Diagnostics Molecular Diagnostics

36.28 %

of total Revenue

Diagnostics Molecular Diagnostics United States

28.14 %

of total Revenue

Diagnostics Molecular Diagnostics International

8.14 %

of total Revenue

Diagnostics Blood Screening

0.93 %

of total Revenue

Diagnostics Blood Screening United States

0.93 %

of total Revenue

Breast Health

41.43 %

of total Revenue

Breast Health United States

32.08 %

of total Revenue

Breast Health International

9.35 %

of total Revenue

Breast Health Breast Imaging

30.86 %

of total Revenue

Breast Health Breast Imaging United States

24.23 %

of total Revenue

Breast Health Breast Imaging International

6.62 %

of total Revenue

Breast Health Interventional Breast Solutions

10.57 %

of total Revenue

Breast Health Interventional Breast Solutions United States

7.85 %

of total Revenue

Breast Health Interventional Breast Solutions International

2.72 %

of total Revenue

GYN Surgical

19.93 %

of total Revenue

GYN Surgical United States

14.21 %

of total Revenue

GYN Surgical International

5.72 %

of total Revenue

Skeletal Health

2.94 %

of total Revenue

Skeletal Health United States

1.52 %

of total Revenue

Skeletal Health International

1.42 %

of total Revenue

Europe

0 %

of total Revenue

Asia-Pacific

0 %

of total Revenue

Rest of World

0 %

of total Revenue

Disposables

70.99 %

of total Revenue

Capital equipment components and software

20.63 %

of total Revenue

Service

23.25 %

of total Revenue

Other

0.6 %

of total Revenue

Hologic Inc Company Profile

Business Description

Fundamental Analysis